NEX Health Intelligence banked €1M in a pre-seed round led by Brighteye Ventures. The funding marks the first institutional capital for the UK-based healthtech startup as it prepares to deploy its software in clinical environments.
The company develops a predictive platform designed to track and forecast the movement of drug-resistant infections within hospitals. By mapping how superbugs spread between patients and wards, the software allows healthcare providers to implement targeted interventions before outbreaks occur, reducing reliance on broad-spectrum antibiotics and manual tracking.
This early-stage investment follows growing pressure on national health systems to address antimicrobial resistance, a factor currently complicating recovery times and operational costs in acute care. NEX Health Intelligence focuses on automating the data analysis usually handled by infection control teams, aiming to turn reactive hospital management into a preventative model.
As European healthcare providers look to digitalise infrastructure to solve staffing and safety bottlenecks, early predictive tools are securing a critical foothold in the next generation of hospital operating systems.
Originally reported by Tech Funding News.